Pune, Maharashtra -- (SBWire) -- 01/30/2017 --Meningococcal Vaccines Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Meningococcal Vaccines globally.
For further information on this report, please visit- http://www.marketreportsworld.com/10279530
The Meningococcal Vaccines Market report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Meningococcal Vaccines Market:
GSK
Pfizer
Sanofi
Other Prominent Vendors of Meningococcal Vaccines Market Are:
Beijing Minhai Biotechnology
Bio Med
Hualan Biological Engineering
Imunoloski Zavod
Availability of combination vaccines is one of the key trends aiding to the growth of this market. Bacterial meningitis is caused by bacteria such as Haemophilus influenzae type B, meningococci, and pneumococci. Combination vaccines for meningitis target multiple causative agents, thereby preventing meningitis caused by these agents. For instance, Menhibrix is approved to prevent invasive meningococcal disease caused by Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y. Thus, combination vaccines eliminate the need to administer individual vaccines. The lower the number of injections administered, the lower the frequency of injection site reactions, such as pain, increasing patient compliance. Increased compliance results in effective prevention of the disease. Combination vaccines also decrease the packaging and transportation expenditure associated with multiple individual vaccines. Collectively, these factors decrease the development and marketing costs of the vaccine and increase the market revenue by effective prevention of the disease.
Ask Sample PDF of Meningococcal Vaccines Market Report @ http://www.marketreportsworld.com/enquiry/request-sample/10279530
According to the Meningococcal Vaccines Market report, the increase in awareness about vaccination and immunization programs will lead to the growth of this market. The WHO conducted a program in over 180 countries in 2013 under the slogan 'Protect your world - get vaccinated'. In 2015, the organization celebrated the European Immunization Week from April 22nd-26th. Every year, the last week of April is observed as the World Immunization Week as per the WHO mandate. In the US, the Association of American Physicians (AAP) and the National Institute of Agricultural Marketing (NIAM) helped increase vaccination coverage in the region. The Amanda Young Foundation is dedicated to reducing the number of deaths from meningococcal disease in Western Australia by organizing activities such as summits and fundraising events to raise awareness about the disease. The foundation also provides funds to support new and ongoing research on the disease.
Report also presents Geographical Segmentation analysis of Meningococcal Vaccines Market of Americas, APAC, EMEA region.
For Any Query, Contact Our Expert @ http://www.marketreportsworld.com/enquiry/pre-order-enquiry/10279530
Further, the Meningococcal Vaccines Market report states that vaccine storage and handling issues is one of the major challenges, decreasing the sales of the vaccine in countries with poor affordability. Vaccines require cold conditions to stay efficacious and are likely to lose their potency if the temperature drops below 35.6 degrees Fahrenheit or goes above 46.4 degrees Fahrenheit. Inadequately stored vaccines lose their efficacy and can cause increased local reactions. Though loss of effectiveness is irreversible, it leads to wastage of vaccine and resources. Thus, the temperature should be maintained at every step of the distribution chain to ensure the supply of potent vaccines. Cold storage requires special machinery and care, which increases the market price of vaccines.
Key questions answered in Meningococcal Vaccines market report:
What will the Meningococcal Vaccines market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving Meningococcal Vaccines market?
What are the challenges to Meningococcal Vaccines market growth?
Who are the key vendors in Meningococcal Vaccines market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
No of Pages: 68
Price of Report: $ 2500 (Single User License)
Purchase Report @ http://www.marketreportsworld.com/purchase/10279530
About Market Reports World
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Contact–
Mr. Ameya Pingaley
Market Reports World
408-520-9750
Email – sales@marketreportsworld.com
http://www.marketreportsworld.com
Meningococcal Vaccines Market Analysis and in-Depth Research on Market Size, Trends, Emerging Growth Factors and Forecasts 2020
Meningococcal Vaccines Market Research Report covers the present scenario and the growth prospects of the Meningococcal Vaccines Industry for 2016-2020.